Drug screening against complement disorders using human stem cell-derived endothelium and liver organoids

2020 ◽  
Vol 73 ◽  
pp. S568-S569
Author(s):  
Yasunori Nio ◽  
Momoko Ohori ◽  
Eri Kawakami ◽  
Tadahiro Shinozawa ◽  
Norikazu Saiki ◽  
...  
Biomolecules ◽  
2021 ◽  
Vol 11 (7) ◽  
pp. 966
Author(s):  
Xv Zhang ◽  
Liling Tang ◽  
Qian Yi

The vasculature of stem-cell-derived liver organoids can be engineered using methods that recapitulate embryonic liver development. Hepatic organoids with a vascular network offer great application prospects for drug screening, disease modeling, and therapeutics. However, the application of stem cell-derived organoids is hindered by insufficient vascularization and maturation. Here, we review different theories about the origin of hepatic cells and the morphogenesis of hepatic vessels to provide potential approaches for organoid generation. We also review the main protocols for generating vascularized liver organoids from stem cells and consider their potential and limitations in the generation of vascularized liver organoids.


Author(s):  
Carolina Reis Oliveira ◽  
Mayara Rodrigues Brandão de Paiva ◽  
Marcela Coelho Silva Ribeiro ◽  
Gracielle Ferreira Andrade ◽  
Juliana Lott Carvalho ◽  
...  

Lab on a Chip ◽  
2017 ◽  
Vol 17 (21) ◽  
pp. 3692-3703 ◽  
Author(s):  
Johan U. Lind ◽  
Moran Yadid ◽  
Ian Perkins ◽  
Blakely B. O'Connor ◽  
Feyisayo Eweje ◽  
...  

Contractility and rate of human stem cell heart tissues.


Sign in / Sign up

Export Citation Format

Share Document